Barron's: Stock buy, dividend hike could boost Pfizer

A big stock buyback or an increased dividend could lift Pfizer shares to $25 over the next year, and the retirement of former CEO Jeff Kindler also gives Pfizer an opportunity to shed assets, Barron's said. Report